References
- Steen VD. Renal involvement in systemic sclerosis. Clin Dermatol 1994;12:253–8.
- Helfrich DJ, Banner B, Steen VD, Medsger TA Jr. Normotensive renal failure in systemic sclerosis. Arthritis Rheum 1989;32:1128–34.
- Steen VD, Medsger TA Jr. Case-control study of corticosteroids and other drugs that either precipitate or protect from the develop-ment of scleroderma renal crisis. Arthritis Rheum 1998;41:1613–9.
- Gondo H, Minematsu T, Harada M, Akashi K, Hayashi S, Taniguchi S, et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 1994;86:130–7.
- Schwarz MI. Diffuse alveolar hemorrhage. In: Schwarz MI, King TE Jr, editors. Interstitial lung disease. 3rd ed. Hamilton, ON: Decker; 1998. p. 535–58.
- Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, Gur H. Pulmonary-renal syndrome in systemic sclerosis. Semin Arthritis Rheum 2001;30:403–10.
- Santiago K, Batuman V, Meleg-Smith S. A 31-year-old woman with lupus erythematosus and fatal multisystem complications. J La State Med Soc 1996;148(9):379–84.
- De Caterina R, Weksler BB. Modulation of arachidonic acid me-tabolism in human endothelial cells by glucocorticoids. Thromb Haemost 1986;55:369–74.
- Mendelsohn FA, Lloyd CJ, Kachel C, Funder JW. Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo. J Clin Invest 1982;70:684–92.
- Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439–43.
- Herkert 0, Kuhl H, Sandow J, Busse R, Schini-Kerth VB. Sex steroids used in hormonal treatment increase vascular procoa-gulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation 2001;104: 2826–31.
- Kahaleh MB, LeRoy EC. Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 1999;31:195–214.
- Kusne S, Grossi P, Irish W, St. George K, Rinaldo C, Rakela J, et al. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1999;68:1125–31.
- Ljungmann P, Griffith P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin SA, editors. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Elsevier Science; 1993. p. 233–7.
- Neidhart M, Kuchen S, Distler 0, Bruhlmann P, Michel BA, Gay RE, et al. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic scle-rosis. Arthritis Rheum 1999;42:389–92.
- Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000;6:1183–6.
- Jeejeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy. Transplantation 1998;65:1645–8.
- Maslo C, Peraldi MN, Desenclos JC, Mougenot B, Cywiner-Golenzer C, Chatelet FP, et al. Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immuno-deficiency virus. Clin Infect Dis 1997;24:350–5.
- Jara LJ, Vera-Lastra 0, Calleja MC. Pulmonary-renal vasculitic disorders: differential diagnosis and management. Curr Ftheumatol Rep 2003;5: 107–15.
- Yamada T, Nakajima H, Tanaka E, Nakajima A, Terai C, Hara M, Kamatani N. Case of systemic sclerosis presenting with alveolar hemorrhage and positive anti-neutrophil cytoplasmic myelo-peroxidase antibody (MPO-ANCA) without pathological renal involvement. Ryumachi 2003;43:690–5.
- Wutzl AL, Foley RN, O'Driscoll BR, Reeve RS, Chisholm R, Herrick AL. Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Rheum 2001;45:533–6.
- Mizutani A, Tanaka I, Katayama M, Oshima H, Komatsu Y, Asano S, K, et al. A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report. Ryumachi 2000;40:828–32.
- Lin AT, Clements PJ, Furst DE. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis. Rheum Dis Clin North Am 2003;29:409–26.